NOVAVAX, INC. (NVAX) Shareholders’ equity 2016–2025
NOVAVAX, INC. (NVAX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$127.8MFY2025 · since FY2016: -$5.5M → -$127.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$127.8M | +79.5% |
| FY2024 | -$623.8M | +13.0% |
| FY2023 | -$716.9M | -13.1% |
| FY2022 | -$634.1M | -80.3% |
| FY2021 | -$351.7M | -156.1% |
| FY2020 | $627.2M | +437.2% |
| FY2019 | -$186.0M | -10.8% |
| FY2018 | -$167.9M | -65.1% |
| FY2017 | -$101.7M | -1734.3% |
| FY2016 | -$5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice